(1 - 19 from 19
)
Atox Bio announces completion of pre-planned safety review
www.biospectrumasia.com
25 Sept — Wayne Dankner, Chief Medical Officer of Atox Bio. "A treatment is needed for this devastating condition and we are hopeful that Reltecimod will ... › news › atox-bio-an...
www.pharmafocusasia.com
... pleased that they have recommended the ACCUTE study continue as designed," said Dr. Wayne Dankner, Chief Medical Officer of Atox Bio.
Atox Bio Announces Independent Safety Arix Biosciencearixbioscience.com › news › atox-bio-announces-independent-safety-monit...
arixbioscience.com
Sep 25, · Dr. Wayne Dankner, Chief Medical Officer of Atox Bio. A DMC is a committee of independent clinical research experts who review data in ...
Atox Bio Announces Independent Safety Lundbeckfondenlundbeckfonden.com › lundbeckfonden-ventures › portfolio › news › atox...
lundbeckfonden.com
... the DMC and are pleased that they have recommended the ACCUTE study continue as designed,” said Dr. Wayne Dankner, Chief Medical Officer of Atox Bio .
sorted by relevance / date